Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987699 | SCV001137118 | likely pathogenic | Patterned macular dystrophy 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001039794 | SCV001203341 | pathogenic | PRPH2-related disorder | 2024-11-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg46*) in the PRPH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRPH2 are known to be pathogenic (PMID: 8111389, 8485575, 8485576, 8675410, 16916875, 17504850, 22863181, 25675413, 26061163, 27365499, 29555955, 33546218). This variant is present in population databases (rs61755771, gnomAD 0.009%). This premature translational stop signal has been observed in individuals with autosomal dominant retinitis pigmentosa (adRP), macular dystrophy, or cone-rod dystrophy (PMID: 7880786, 8111389, 25447119, 28559085, 29555955). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13179). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001075450 | SCV001241073 | pathogenic | Retinal dystrophy | 2018-09-21 | criteria provided, single submitter | clinical testing | |
NEI Ophthalmic Genomics Laboratory, |
RCV001250276 | SCV001424588 | pathogenic | Stargardt disease | 2020-01-07 | criteria provided, single submitter | clinical testing | The variant NM_000322.4:c.136C>T in the PRPH2 gene has been previously studied (PMIDs 8111389, 20213611, 23105016, 25412400, 25412400, 28559085, 29555955, 29343940). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755771,CM930635). It is present in gnomAD browser (AF 0.0000163). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PVS1, PS4, PM2, PP1-M, PP5] and classified NM_000322.4:c.136C>T in the PRPH2 gene as a Pathogenic mutation. |
NEI Ophthalmic Genomics Laboratory, |
RCV001250291 | SCV001424604 | pathogenic | Patterned dystrophy of the retinal pigment epithelium | 2020-01-07 | criteria provided, single submitter | clinical testing | The variant NM_000322.4:c.136C>T in the PRPH2 gene has been previously studied (PMIDs 8111389, 20213611, 23105016, 25412400, 25412400, 28559085, 29555955, 29343940). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755771,CM930635). It is present in gnomAD browser (AF 0.0000163). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PVS1, PS4, PM2, PP1-M, PP5] and classified NM_000322.4:c.136C>T in the PRPH2 gene as a Pathogenic mutation. |
Institute of Human Genetics, |
RCV000987699 | SCV001441038 | pathogenic | Patterned macular dystrophy 1 | 2023-03-06 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PVS1, PS4 |
Gene |
RCV000084955 | SCV001783412 | pathogenic | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32660024, 28559085, 29343940, 29555955, 25447119, 7880786, 11139241, 8111389, 26061163, 25412400, 7825692, 20213611, 28129423, 32531846, 23105016) |
MGZ Medical Genetics Center | RCV000987699 | SCV002580655 | pathogenic | Patterned macular dystrophy 1 | 2022-01-25 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001075450 | SCV004707364 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Genomic Medicine Center of Excellence, |
RCV003987319 | SCV004804689 | pathogenic | Choroidal dystrophy, central areolar 2 | 2024-03-17 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV001075450 | SCV005072312 | pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000014067 | SCV000034314 | pathogenic | Retinitis pigmentosa 7 | 1995-01-01 | no assertion criteria provided | literature only | |
Retina International | RCV000084955 | SCV000117091 | not provided | not provided | no assertion provided | not provided | ||
Leiden Open Variation Database | RCV000084955 | SCV001745055 | pathogenic | not provided | 2021-04-29 | no assertion criteria provided | curation | Curator: Global Variome, with Curator vacancy. Submitters to LOVD: Julia Lopez, LOVD, Manon Peeters, Yoshito Koyanagi. Comment: Variant observed de novo. |
Ophthalmo- |
RCV001250276 | SCV002761252 | pathogenic | Stargardt disease | 2022-12-13 | no assertion criteria provided | research |